Mitral transcatheter edge-to-edge repair resulted in comparable all-cause mortality to surgery (RR 1.02) at 18 months, but had higher rates of heart failure rehospitalization and reintervention.
Meta-Analysis (n=23,825)
Yes
Does mitral transcatheter edge-to-edge repair reduce mortality and heart failure rehospitalization compared to surgery in patients with severe mitral regurgitation?
In patients with severe mitral regurgitation, m-TEER provides comparable mid-term survival to surgery, but surgery is associated with lower rates of heart failure rehospitalization, mitral reintervention, and residual MR.
Effect estimate: RR 1.02 (95% CI 0.77-1.37)
p-value: p=0.87
Abstract Aims To compare outcomes of patients with severe mitral regurgitation (MR) after m-TEER and surgery. Methods and results PubMed, Scopus, and Google Scholar databases were searched for randomized controlled trials and propensity score matching studies comparing mid-term outcomes of m-TEER vs. surgical valve repair. All-cause of death, rehospitalization for heart failure, mitral reintervention, NYHA class at clinical follow-up and grade ≥ 3 at echocardiographic follow-up were the outcomes of interest. Additional sensitivity analyses were performed to account for heterogeneity. Nine studies (2 RCT and 7 propensity score matching studies) with a total of 23 825 patients (m-TEER group = 11 970; surgery group = 11 855) were included. Surgery and m-TEER were associated with comparable rates of all-cause mortality at a median follow-up of 18 months (RR 1.02, 95%CI 0.77–1.37, P-value 0.87). Surgical repair was associated with a reduced risk of rehospitalization for heart failure (RR 1.70, 95%CI 1.47–1.98, P value 0.01) and mitral reintervention (RR 3.27, 95%CI 2.49–4.30, P value 0.01), due to a reduced at least moderate residual MR (RR 6.35, 95%CI 1.43–28.22, P value 0.02). Conclusion In patients with severe MR, m-TEER resulted in comparable outcomes for all-cause deaths compared to surgery, although the latter was associated with reductions in heart failure rehospitalization, reintervention and MR residual rates at a median 18-month follow-up.
Pietro et al. (Tue,) conducted a meta-analysis in Severe mitral regurgitation (n=23,825). Mitral transcatheter edge-to-edge repair (m-TEER) vs. Surgery (surgical valve repair or replacement) was evaluated on All-cause mortality (RR 1.02, 95% CI 0.77-1.37, p=0.87). Mitral transcatheter edge-to-edge repair resulted in comparable all-cause mortality to surgery (RR 1.02) at 18 months, but had higher rates of heart failure rehospitalization and reintervention.